Close Menu
    Subscribe
    Uncategorized

    Emergent BioSolutions’ stock soars 23% after FDA approves its smallpox vaccine for mpox

    By No Comments1 Min Read

    The Emergent vaccine is now the second one to win FDA approval after one developed by Danish biotech Bavarian Nordic.

    Oh hi there 👋
    It’s nice to meet you.

    Sign up to receive awesome content in your inbox, every month.

    We don’t spam! Read our privacy policy for more info.

    Share.

    Related Posts

    Add A Comment
    Leave A Reply